Biohaven Stock Is Plunging Today – Here’s Why
Biohaven Ltd (NASDAQ: BHVN) shares are down after the company announced multiple
European Commission Approves Gilead’s Trodelvy For Pre-Treated HR+/HER2- Metastatic Breast Cancer
-- Approval Based on Clinically Meaningful Overall Survival Benefit Demonstrated in the TROPiCS-02 Study in Pre-Treated HR+/HER2- (IHC 0, IHC 1+ or IHC 2+/ISH–) Metastatic Breast Cancer vs. Physician's Choice
Novo Nordisk’s Wegovy Supply Delays: FDA Uncovers Catalent Factory Lapses Violating Safety Regulations
The production facility that fills the self-injection pens for the rapidly-growing weight-loss medication Wegovy from Novo Nordisk A/S (NYSE: NVO) has been found to have persistently violated U.S.
Inozyme Outlines Plans For Pediatric Trial For ENPP1 Deficiency Treatment: Targets 2026 Commercial Launch For INZ-701
Following meetings with the FDA and the European Medicines Agency's Paediatric Committee, Inozyme Pharma Inc (NASDAQ: INZY) updated its global development strategy for INZ-701, a
Abbott Recalls Amplatzer Steerable Delivery Sheath On Risk Of Air Embolism
Abbott Laboratories (NYSE: ABT) is recalling the Amplatzer Steerable Delivery Sheath due to an increased
Novo Nordisk’s Ozempic And Wegovy Under Scrutiny Amid Reports Of ‘Stomach Paralysis’
Popular weight loss and diabetes drugs, Ozempic and Wegovy, have reportedly caused stomach paralysis in some users. What…
Tarsus Pharma Shares Under Pressure: Analyst Says Concerns Over Adverse Event Profile Overblown
The FDA approved Tarsus Pharmaceuticals Inc's (NASDAQ: TARS) Xdemvy (lotilaner ophthalmic solution) 0.25% for
‘As Alzheimer’s Drugs Hit The Market, The Race For Early Detection Blood Tests Heats Up’ – Stat News
https://www.statnews.com/2023/07/25/alzheimers-blood-test-diagnostics-leqembi/
ith the advent of disease-modifying Alzheimer’s drugs, everyone in the world of Alzheimer’s diagnostics is bracing for the
PaxMedica’s Successful Trial Paves the Way For First US-Approved Drug For African Sleepiness
PaxMedica Inc (NASDAQ: PXMD) shares are trading higher after the company released topline data from PAX-HAT-301 Retrospective Analysis of Suramin Treatment for Stage 1 Trypanosoma Brucei Rhodesiense Human African
Why Becton Dickinson Stock Is Trading Higher Today?
The FDA approved BD's (Becton, Dickinson, and Company) (NYSE: BDX) BD Alaris Infusion System with 510(k) clearance, which enables both remediation and a return to full commercial operations for the most comprehensive